ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
Paul G. Kemps(Leiden University Medical Center), Brianna Empringham(University of Toronto), Uta Flucke(Princess Máxima Center), Martin Ebinger(University Children's Hospital Tübingen), Susan Picton(Helios Klinikum Emil von Behring), Jacinthe Bonneau‐Lagacherie, Laura S. Hiemcke‐Jiwa(Princess Máxima Center), Bożenna Dembowska–Bagińska(Children's Memorial Health Institute), Alysa Poulin(University of Saskatchewan), Gianpiero Tamburrini(Università Cattolica del Sacro Cuore), Robert Möhle(University of Tübingen), Jan van Laar(Erasmus MC), В. Г. Потапенко(City Clinical Hospital No 31), D. A. Evseev(Kepler Universitätsklinikum), Claire Lamaison(Inserm), Jean Donadieu(Sorbonne Université), Falko Fend(Universitätsklinikum Tübingen), Sabrina Rossi(Bambino Gesù Children's Hospital), Matthew Collin(Newcastle upon Tyne Hospitals NHS Foundation Trust), Karen Ernestus(University of Würzburg), Stefania Gaspari(Bambino Gesù Children's Hospital), Benjamin H. Durham(Rutgers, The State University of New Jersey), Robert M. Verdijk(Leiden University Medical Center), Olga Gryniewicz–Kwiatkowska(Children's Memorial Health Institute), Zofia Hélias‐Rodzewicz(Université de Versailles Saint-Quentin-en-Yvelines), Ingrid S. Tam(University of Saskatchewan), Tina Méry(Klinikum Chemnitz), Marianne D. van de Wetering(Amsterdam UMC Location University of Amsterdam), V. V. Baykov(First Pavlov State Medical University of St. Petersburg), Marco Gessi(Universität Hamburg), Friedrich Feuerhake(Medizinische Hochschule Hannover), Carel J.M. van Noesel(Amsterdam University Medical Centers), Jennifer Picarsic(University of Pittsburgh), Laure Farnault(Aix-Marseille Université), Sébastien Héritier(Sorbonne Université), Feng Jung Sherida H. Woei-A-Jin(KU Leuven), Verena Wiegering(Universitätsklinikum Würzburg), Marie‐Laure Jullié(Centre Hospitalier Universitaire de Bordeaux), Dina El Demellawy(Children's Hospital of Eastern Ontario), Majid Madni(Nottingham University Hospitals NHS Trust), Kerry Turner, Cor van den Bos(Princess Máxima Center), Raf Sciot(KU Leuven), Pasquale Barbaro(Children's Health Queensland Hospital and Health Service), Jackie Allotey, Julien Haroche(Inserm), Pancras C.W. Hogendoorn(Vrije Universiteit Brussel), Antje Bornemann(University Children's Hospital Tübingen), Sylvie Fraitag(Hôpital Necker-Enfants Malades)
Cited by 157
Related Papers
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
|The Lancet Oncology|2014|1.2k
The Clinical Approach Towards Chondrosarcoma
|The Oncologist|2008|738